HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yingxue Chen Selected Research

Yingxue Chen Research Topics

Disease

4Asthma (Bronchial Asthma)
01/2022 - 01/2016
2Infections
01/2023 - 01/2016
1Neoplasms (Cancer)
01/2022
1Malignant Mesothelioma
01/2022
1Ovarian Hyperstimulation Syndrome
10/2019
1Inflammation (Inflammations)
02/2019
1Chronic Obstructive Pulmonary Disease (COPD)
01/2019
1Ataxia Telangiectasia (Louis Bar Syndrome)
10/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2016

Drug/Important Bio-Agent (IBA)

3velsecoratIBA
01/2022 - 01/2019
3Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2022 - 01/2019
1tazemetostatIBA
01/2022
1Pemetrexed (MTA)FDA Link
01/2022
1Enhancer of Zeste Homolog 2 ProteinIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1cetrorelix (Cetrotide)FDA Link
10/2019
1ganirelixFDA Link
10/2019
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
10/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2019
1Bronchodilator Agents (Bronchodilators)IBA
02/2019
1PyransIBA
10/2018
1AZD0156IBA
10/2018
1Phosphotransferases (Kinase)IBA
10/2018
1ErbB Receptors (EGF Receptor)IBA
01/2018
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2018
1Gefitinib (Iressa)FDA Link
01/2018
1Testosterone (Sustanon)FDA Link
01/2016

Therapy/Procedure

1Photothermal Therapy
01/2023
1Phototherapy (Light Therapy)
01/2023
1Aftercare (After-Treatment)
01/2022
1Therapeutics
01/2022
1Patient Discharge
01/2016
1Length of Stay
01/2016